ArticleMedicine2026
Association of the atherogenic index of plasma and derived indicators with future risk of liver diseases and alcoholic liver disease among Chinese middle-aged and elderly adults: A nationwide cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The precise association between the atherogenic index of plasma (AIP) and its derived anthropometric indicators and the future risk of liver diseases and alcoholic liver disease among Chinese middle-aged and elderly adults remains unclear. The study population was derived from the China Health and Retirement Longitudinal Study. Incident liver disease cases were identified based on self-reported questionnaire information. The AIP and its related indicators were calculated using laboratory results from participants blood samples. We employed Cox regression to assess the associations between cumulative and categorical AIP, as well as related indicators, and the occurrence of liver disease. Additionally, restricted cubic splines were used to examine potential nonlinear relationships between cumulative AIP and liver disease risk. The mean age of the 9027 participants was 61.20 ± 9.54 years, and 438 (4.85%) subjects developed liver disease during a median follow-up duration of 7 years. After full adjustment for confounders, each 1-standard deviation increase in AIP was associated with a 15% higher risk of liver disease (HR = 1.15; 95% confidence intervals: 1.02-1.30; P = .020). Similarly, higher levels of AIP-BMI, AIP-WC, and AIP-BRI were associated with increased liver disease risk. restricted cubic splines analyses visually confirmed a positive dose-response relationship between AIP and its related indicators and liver disease risk, with no significant nonlinear trends. Additionally, subgroup analyses and sensitivity analyses confirmed that higher levels of AIP are associated with a higher risk of liver disease. In this national cohort, higher AIP was associated with an increased risk of self-reported liver disease. Long-term monitoring of AIP may help identify individuals for further hepatic assessment. However, confounding from unmeasured factors including viral hepatitis cannot be ruled out.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.